{
  "docId": "019de512-1d9c-77ac-89a7-37c31d2fe456",
  "docSlug": "7c215450e91c4a5bf3cd78ec1696c390",
  "documentTitle": "Avantor | Investor Conference Presentation Deck | 26 slides",
  "authorId": "avantor",
  "authorName": "Avantor",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2022-01-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 11,
  "pageCount": 26,
  "prevPage": 10,
  "nextPage": 12,
  "slideType": "key_messages",
  "function": "establish_context",
  "density": "dense",
  "nDataPoints": 18,
  "notes": "The slide uses a three-column layout to present distinct market indicators.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de512-1d9c-77ac-89a7-37c31d2fe456/11",
  "deckHref": "/decks/019de512-1d9c-77ac-89a7-37c31d2fe456",
  "deckJsonHref": "/decks/019de512-1d9c-77ac-89a7-37c31d2fe456.json",
  "deckAnchorHref": "/decks/019de512-1d9c-77ac-89a7-37c31d2fe456#slide-11",
  "components": [
    {
      "bbox": {
        "h": 0.5,
        "w": 0.3,
        "x": 0.35,
        "y": 0.35
      },
      "kind": "chart",
      "text": "Est. worldwide biopharma drug revenue",
      "attrs": null,
      "subkind": "bar-horizontal",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "1fd159ed-dd19-4de6-ac63-e3663ccbfa03",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.5,
        "w": 0.25,
        "x": 0.7,
        "y": 0.35
      },
      "kind": "chart",
      "text": "FDA new molecular entity approvals",
      "attrs": null,
      "subkind": "bar-stacked-vertical",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "773c6eda-85ca-4833-81f1-d9cedb8fda45",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.5,
        "w": 0.25,
        "x": 0.05,
        "y": 0.35
      },
      "kind": "chart",
      "text": "Total worldwide venture funding raised by biotech companies",
      "attrs": null,
      "subkind": "bar-vertical",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "7a9a40d8-2fca-46aa-98f8-ec59810ed362",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.06,
        "w": 0.45,
        "x": 0.19,
        "y": 0.92
      },
      "kind": "source-note",
      "text": "1. BCIQ (Oct 2021)... 2. Includes traditional mAbs... 3. FDA, Nephron Research as of 11/30/21",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "b9f3c522-785f-4866-8bc0-b1d467e47af8",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.12,
        "w": 0.65,
        "x": 0.03,
        "y": 0.05
      },
      "kind": "title",
      "text": "Avantor growth fueled by strong biopharma industry fundamentals...",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "5008147b-44ca-4e56-9483-08386b2dc3e0",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [
    {
      "name": "MECE-principle",
      "slug": null,
      "matchId": "11863fe9-1939-4736-bd8b-3975a55b95e4",
      "evidence": "The slide categorizes industry drivers into three distinct, non-overlapping pillars.",
      "confidence": 0.8
    }
  ],
  "arcBeats": [
    {
      "to": 11,
      "from": 10,
      "beatId": "02661f13-7555-4d88-a517-9740fe4c5491",
      "arcName": "The Sparkline",
      "arcSlug": "sparkline",
      "beatName": "Solution",
      "beatSlug": null,
      "evidence": "The presentation proposes Avantor Business System (ABS) as a solution to drive growth and value creation.",
      "position": 4,
      "confidence": 0.8,
      "parentBeatName": null,
      "parentBeatSlug": null
    }
  ],
  "loops": [
    {
      "to": 11,
      "from": 10,
      "name": "Quick Win Big Bet",
      "slug": "47-quick-win-big-bet",
      "bestFor": "Transformation planning, 100-day plans, resource allocation",
      "matchId": "0a25eb60-8383-4a37-8c99-1efc5a436cdd",
      "evidence": "The presentation discusses Avantor's business system and growth drivers, highlighting the company's quick wins and big bets.",
      "position": 1,
      "objective": "Highlight Avantor's quick wins and big bets for growth",
      "structure": "The Full List -> Quick Wins (Low effort, High impact) -> Big Bets (High effort, High impact) -> Sequenced Roadmap",
      "confidence": 0.6,
      "description": "Separate initiatives into immediate wins and longer-term strategic bets"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}